The melanocortin system

The melanocortin system is one of biology's most economical signalling arrangements. A single gene encodes a single precursor protein — pro-opiomelanocortin, or POMC — which is then cut into a family of short peptides. Those peptides act on five related receptors, are opposed by two natural antagonists, and between them regulate processes as different as the colour of your hair, the cortisol released under stress, how much you eat, and how inflammation resolves.^[1] The economy is the point: the same molecular toolkit is reused across organs, with specificity coming not from the messenger but from where it is made and which receptor receives it.

One gene, many messages

POMC is a prohormone — a long, inert precursor that has to be cut to become active. The cutting is done by enzymes called prohormone convertases, chiefly PC1/3 and PC2, which snip the chain at specific pairs of basic amino acids.^[2] Crucially, different tissues carry different convertases, so the same POMC molecule yields different products depending on where it is processed.^[4]

• In the anterior pituitary, PC1/3 dominates. Processing largely stops at adrenocorticotropic hormone (ACTH) and β-lipotropin.
• In the hypothalamus, intermediate pituitary, and skin, both PC1/3 and PC2 are present, so ACTH is cut further into α-melanocyte-stimulating hormone (α-MSH), and β-lipotropin into β-endorphin.^[2]

This is why ACTH is the dominant pituitary output that drives the adrenal gland, while α-MSH — the classic pigment and appetite signal — is generated in the brain and skin.

The melanocortin peptides

The peptides cut from POMC fall into two functional groups. Themelanocortins proper — α-, β-, and γ-MSH and ACTH — share a common core sequence (His-Phe-Arg-Trp) that is the business end for receptor binding.^[1] Alongside them, the same precursor releases β-endorphin, an opioid peptide, underscoring how much functional range is packed into one gene.^[2]

Different melanocortins prefer different receptors. α-MSH is the broadest agonist; ACTH is the only peptide that meaningfully activates the adrenal receptor; and the relative potencies of β- and γ-MSH vary by receptor subtype.^[3]

Five receptors that read the signal

The melanocortins act through five G-protein-coupled receptors, MC1R through MC5R. All five couple to the stimulatory G-protein Gs, raising intracellular cyclic AMP when activated — a shared mechanism that nonetheless produces very different outcomes because each receptor sits in a different tissue.^[3]

• MC1R — melanocytes; the switch between red/yellow and brown/black pigment.
• MC2R — adrenal cortex; the ACTH receptor that drives cortisol.
• MC3R — hypothalamus and periphery; energy partitioning and inflammation.
• MC4R — central nervous system; the master control of appetite and weight.
• MC5R — exocrine glands; secretion, including sebum.

Two of the receptors are unusual. MC2R responds only to ACTH and cannot even reach the cell surface without a dedicated chaperone, the melanocortin receptor accessory protein MRAP — a reminder that the system's specificity is built from accessory machinery as much as from the receptors themselves.^[3] See the receptor overview for a page on each.

The brakes: agouti and AgRP

Most signalling systems are switched on by agonists and simply fade when the agonist leaves. The melanocortin system is rarer: it has endogenousantagonists that actively oppose it. Agouti signalling protein blocks MC1R in the skin — the mechanism behind the banded coat colour of agouti mice — while agouti-related peptide (AgRP) blocks MC3R and MC4R in the brain, and at MC4R behaves as an inverse agonist, pushing activity below baseline.^[1] The push-and-pull of α-MSH against AgRP in the hypothalamus is one of the body's central controllers of appetite.

What the system does

Because the same peptides reach different receptors in different tissues, the melanocortin system shows up across an unusually wide span of physiology:^[1]

• Pigmentation — α-MSH at MC1R drives protective eumelanin and the UV-tanning response.
• The stress axis — ACTH at MC2R is the final step of the hypothalamic–pituitary–adrenal axis, releasing cortisol.
• Energy balance — α-MSH at MC4R suppresses appetite; loss of MC4R signalling is the commonest single-gene cause of severe obesity.
• Inflammation — melanocortins at MC1R and MC3R are broadly anti-inflammatory and pro-resolving.
• Exocrine and other roles — secretion, natriuresis, sexual function, and thermoregulation all carry a melanocortin contribution.

Why it matters in the clinic

Each of these levers is now a therapeutic target. Agonists of MC4R are used for rare genetic obesity, MC1R agonists for a light-sensitivity disorder, and melanocortin agonists for sexual dysfunction — with a broader anti-inflammatory frontier still being explored. Thetherapeutics section covers approved and investigational agents, each verified against current sources.

References

1. 1.Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 27(7):736–49. 2006. link ↗
2. 2.Harno E, Gali Ramamoorthy T, Coll AP, White A. POMC: The Physiological Power of Hormone Processing. Physiol Rev. 98(4):2381–2430. 2018. link ↗
3. 3.Cooray SN, Clark AJL. The melanocortin receptors and their accessory proteins. Front Endocrinol (Lausanne). 4:9. 2013. link ↗
4. 4.Harno E, et al. Biosynthesis, trafficking, and secretion of POMC-derived peptides. Review (PMC4899099). 2016. link ↗